Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06944392 · ClinicalTrials.gov registry record · NA
Evaluating Pumpkin Seed Oil Extract Supplementation on Bladder Function
A NA study of Overactive Bladder (OAB), sponsored by Northwestern University.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06944392: Recruiting NA study of Overactive Bladder (OAB), sponsored by Northwestern University.
NCT06944392 is a NA study of Overactive Bladder (OAB) that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 40 participants, below the 286-participant average among 7 other Overactive Bladder (OAB) trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06944392, a NA study of Overactive Bladder (OAB), is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot study to assess using validated outcome measures how ingesting pumpkin seed oil extract supports patient bladder function in a United States population.
Primary Outcome
Assess changes in patient-reported bladder function reflected through their responses on the LURN-SI survey.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Pumpkin Seed Extract
Study Locations (1)
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-04-11 |
| Est. Completion | 2026-07-01 |
| Phase | NA |
What NCT06944392 shows while recruiting
NCT06944392 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 286-participant average among 7 other Overactive Bladder (OAB) trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Overactive Bladder (OAB) appearing as the primary indexed condition, and to 1 intervention - of which Pumpkin Seed Extract is the first listed.
NCT06944392 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06944392 about?
NCT06944392 is a clinical study titled "Evaluating Pumpkin Seed Oil Extract Supplementation on Bladder Function". This is a pilot study to assess using validated outcome measures how ingesting pumpkin seed oil extract supports patient bladder function in a United States population.
What is the current status of trial NCT06944392?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-04-11. Estimated completion is 2026-07-01.
What conditions does trial NCT06944392 study?
This clinical trial studies the following conditions: Overactive Bladder (OAB).
What interventions are being tested in trial NCT06944392?
The interventions under investigation include: Pumpkin Seed Extract (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06944392?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06944392 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overactive Bladder (OAB)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
PMCF Study of the Axonics SNM System Model 5101 (R20)
RECRUITING · NA
-
Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women
RECRUITING · NA
-
Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)
RECRUITING · NA
-
APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women
RECRUITING · NA
-
Zinc Supplementation With Botulinum Toxin for Overactive Bladder
RECRUITING · Phase 2
-
Assessing the Genitourinary Microbiome of Women With Overactive Bladder Undergoing Onabotulinum Toxin Type A Intradetrusor Injections
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI